Detalles de la búsqueda
1.
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing.
Cytotherapy
; 26(3): 266-275, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38231165
2.
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer.
J Immunother Cancer
; 9(11)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34815355
Resultados
1 -
2
de 2
1
Próxima >
>>